Summary

Global Wearable Tremor Therapy Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Wearable tremor is the use of wearable devices or technologies designed to alleviate or manage tremors experienced by individuals with conditions such as Parkinson's disease or essential tremors. These devices typically employ sensors and actuators to detect and counteract involuntary shaking movements in real-time. The therapy aims to provide continuous, non-invasive support to individuals affected by tremors, helping them regain control over their movements and improve their quality of life. The Wearable Tremor Therapy market is expanding because of factors such as the rising prevalence of neurological disorders, rising preference for non-invasive treatments, and favorable government initiatives and support for promoting innovation in healthcare technology.

A study supported by the Parkinson's Foundation in late 2022 uncovered a significant rise in Parkinson's disease (PD) diagnoses in the United States. The findings revealed that approximately 90,000 individuals are diagnosed with PD each year, marking a substantial 50% increase compared to the previously estimated annual diagnosis rate of 60,000. Additionally, findings from a 2023 study by the World Federation of Neurology indicate that over 40% of the global population currently grapples with some form of neurological condition. This burden is expected to nearly double by 2050, underscoring the pressing need for effective interventions and treatments in the field of neurology. Thus, the rising prevalence of neurological disorders is driving the market growth. In addition, rising healthcare expenditure and ongoing technological advancement are creating new opportunities for market growth. However, the availability of alternative treatment options and stringent regulatory requirements for product approval stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Wearable Tremor Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. North America emerged as the leading market for wearable tremor therapy, a trend expected to persist throughout the forecast period. This dominance is primarily attributed to the robust presence of domestic companies in the United States, spearheading the development and commercialization of tremor-reducing devices. These companies are actively engaged in obtaining regulatory approvals for their products, thereby fueling market expansion. For example, in June 2023, Cala Health introduced its latest innovation, the Cala kIQ System, designed to alleviate hand tremors in individuals with essential tremors and Parkinson's disease. This system, cleared by the Food and Drug Administration (FDA), utilizes Transcutaneous Afferent Patterned Stimulation (TAPS) to temporarily alleviate symptoms of postural and kinetic tremors. Such advancements underscore the proactive role of U.S. manufacturers in driving innovation and growth within the Wearable Tremor Therapy Market. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, rising disease prevalence, and rising technological advancement in the region.

Major market players included in this report are:
Cala Health, Inc.
Allevion Therapeutics
Abbott Laboratories
Medtronic plc
Steadiwear Inc.
Five Microns
Neater Solutions Ltd.
Lift Labs
Encora Therapeutics
BrainQ


Recent Developments in the Market:
 In March 2022, Allevion Therapeutics disclosed the successful evaluation of its Allevx device in the United States. This device underwent clinical testing involving 14 patients with movement disorders, including essential tremor and Parkinson's disease. Remarkably, all patients experienced a reduction in tremors following the therapy.
 In March 2021, Encora Therapeutics achieved Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its wristband designed to alleviate hand tremors in adults with essential tremors or Parkinson's disease.

Global Wearable Tremor Therapy Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Anatomical Location, Product Type, Distribution Channel, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
 Customization Scope - Free report customization (equivalent to up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Anatomical Location:
Wrist
Hand
Others
By Product Type:
Mechatronics Systems
Handheld External Devices
Orthosis
By Distribution Channel:
Hospital and Retail Pharmacies
Online Stores
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico
ROLA

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Wearable Tremor Therapy Market, by Region, 2020-2030 (USD Billion)
1.2.2. Wearable Tremor Therapy Market, by Anatomical Location, 2020-2030 (USD Billion)
1.2.3. Wearable Tremor Therapy Market, by Product Type, 2020-2030 (USD Billion)
1.2.4. Wearable Tremor Therapy Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Wearable Tremor Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Wearable Tremor Therapy Market Dynamics
3.1. Wearable Tremor Therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Neurological Disorders
3.1.1.2. Rising Preference for Non-Invasive Treatments
3.1.1.3. Favorable Government Initiatives and Support for Promoting Innovation in Healthcare Technology
3.1.2. Market Challenges
3.1.2.1. Availability of Alternative Treatment Options
3.1.2.2. Stringent Regulatory Requirements for Product Approval
3.1.3. Market Opportunities
3.1.3.1. Rising Healthcare Expenditure
3.1.3.2. Ongoing Technological Advancements
Chapter 4. Global Wearable Tremor Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Wearable Tremor Therapy Market, by Anatomical Location
5.1. Market Snapshot
5.2. Global Wearable Tremor Therapy Market by Anatomical Location, Performance - Potential Analysis
5.3. Global Wearable Tremor Therapy Market Estimates & Forecasts by Anatomical Location 2020-2030 (USD Billion)
5.4. Wearable Tremor Therapy Market, Sub Segment Analysis
5.4.1. Wrist
5.4.2. Hand
5.4.3. Others
Chapter 6. Global Wearable Tremor Therapy Market, by Product Type
6.1. Market Snapshot
6.2. Global Wearable Tremor Therapy Market by Product Type, Performance - Potential Analysis
6.3. Global Wearable Tremor Therapy Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
6.4. Wearable Tremor Therapy Market, Sub Segment Analysis
6.4.1. Mechatronics Systems
6.4.2. Handheld External Devices
6.4.3. Orthosis
Chapter 7. Global Wearable Tremor Therapy Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Wearable Tremor Therapy Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Wearable Tremor Therapy Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Wearable Tremor Therapy Market, Sub Segment Analysis
7.4.1. Hospital and Retail Pharmacies
7.4.2. Online Stores
7.4.3. Others
Chapter 8. Global Wearable Tremor Therapy Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Wearable Tremor Therapy Market, Regional Market Snapshot
8.4. North America Wearable Tremor Therapy Market
8.4.1. U.S. Wearable Tremor Therapy Market
8.4.1.1. Anatomical Location breakdown estimates & forecasts, 2020-2030
8.4.1.2. Product Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Wearable Tremor Therapy Market
8.5. Europe Wearable Tremor Therapy Market Snapshot
8.5.1. U.K. Wearable Tremor Therapy Market
8.5.2. Germany Wearable Tremor Therapy Market
8.5.3. France Wearable Tremor Therapy Market
8.5.4. Spain Wearable Tremor Therapy Market
8.5.5. Italy Wearable Tremor Therapy Market
8.5.6. Rest of Europe Wearable Tremor Therapy Market
8.6. Asia-Pacific Wearable Tremor Therapy Market Snapshot
8.6.1. China Wearable Tremor Therapy Market
8.6.2. India Wearable Tremor Therapy Market
8.6.3. Japan Wearable Tremor Therapy Market
8.6.4. Australia Wearable Tremor Therapy Market
8.6.5. South Korea Wearable Tremor Therapy Market
8.6.6. Rest of Asia Pacific Wearable Tremor Therapy Market
8.7. Latin America Wearable Tremor Therapy Market Snapshot
8.7.1. Brazil Wearable Tremor Therapy Market
8.7.2. Mexico Wearable Tremor Therapy Market
8.8. Middle East & Africa Wearable Tremor Therapy Market
8.8.1. Saudi Arabia Wearable Tremor Therapy Market
8.8.2. South Africa Wearable Tremor Therapy Market
8.8.3. Rest of Middle East & Africa Wearable Tremor Therapy Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Cala Health, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Allevion Therapeutics
9.3.3. Abbott Laboratories
9.3.4. Medtronic plc
9.3.5. Steadiwear Inc
9.3.6. Five Microns
9.3.7. Neater Solutions Ltd.
9.3.8. Lift Labs
9.3.9. Encora Therapeutics
9.3.10. BrainQ
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption